Alerginiu Susirgimu Diagnostikos Ir Gydymo Centras UAB
- Address
- Seliu G. 64, Vilniaus M. Sav., 08109 Vilnius, Lithuania
Alerginiu Susirgimu Diagnostikos Ir Gydymo Centras UAB - Allergic Diseases Research Center
Alerginiu Susirgimu Diagnostikos Ir Gydymo Centras UAB is a specialized medical research facility dedicated to advancing the diagnosis and treatment of allergic disorders. The center focuses on conducting pivotal Phase 3 clinical trials investigating novel therapeutic approaches and biosimilar agents for complex allergic conditions, with particular emphasis on chronic inflammatory and immunological diseases.
- Chronic spontaneous urticaria treatment optimization and novel biologic therapies
- Biosimilar therapeutic equivalence studies for established immunological agents
- Allergen-specific immunotherapy for house dust mite-induced respiratory allergies
The center's research portfolio encompasses comprehensive evaluation of urticaria activity management through advanced assessment tools including weekly urticaria activity scoring, and exploration of subcutaneous immunotherapy protocols for moderate to severe allergic rhinitis and rhinoconjunctivitis. Their expertise extends to evaluating therapeutic responses in patients with inadequate antihistamine response, contributing valuable data to the development of next-generation biologic therapies and treatment algorithms for challenging allergic conditions including asthma comorbidity.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 2 therapeutic areas and 15 of 32 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1Celldex Therapeutics Inc.2active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Celldex Therapeutics Inc.3trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 79 other sites in Lithuania
Therapeutic Area Benchmark — Lithuania
Select a therapeutic area to compare against other sites in Lithuania.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Lithuania
Market Share
Country: Lithuania
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Alerginiu Susirgimu Diagnostikos Ir Gydymo Centras UAB
lock Showing 1 of 5 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of Barzolvolimab in Participants with Cold-Induced Urticaria and Symptomatic Dermographism | Celldex Therapeutics Inc. | Phase III | Recruiting | Apr 2026 | — |
IMP list
lock Showing 1 of 32 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Barzolvolimab | 3 | Unknown | 2025-04-04 | 2026-04-20 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.